The Analyst Landscape: 6 Takes On Silence Therapeutics
The Analyst Landscape: 6 Takes On Silence Therapeutics
分析師視角：關於Silence Therapeutics的六種看法
A clear picture of Silence Therapeutics's perception among...Silence Therapeutics (NASDAQ:SLN) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Silence Therapeutics（納斯達克：SLN）在上個季度接受了6位分析師的分析，顯示出從看好到看淡的不同觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們近期評級的彙總視圖，展示了過去30天的情緒變化，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Silence Therapeutics, revealing an average target of $64.0, a high estimate of $75.00, and a low estimate of $49.00. The average price target has stayed the same, reflecting a consistent view from analysts.
分析師爲Silence Therapeutics設定了12個月的價格目標，平均目標爲$64.0，最高估計爲$75.00，最低估計爲$49.00。平均價格目標保持不變，反映了分析師的一致觀點。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
A clear picture of Silence Therapeutics's perception among...
通過對近期分析師行...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。